Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01697215 · ClinicalTrials.gov registry record
Novel Device to Assess Endotracheal Tube Migration
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 42
- Enrollment target
NCT01697215: Completed study, sponsored by The Cleveland Clinic.
NCT01697215 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01697215 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
To evaluate the ability of the SonarMed AirWave to provide clinicians with information that enables them to confirm continuous proper placement of the endotracheal tube. This initial study is prospective, observational, looking at CXR results, and comparing those to AirWave system output data.
Primary Outcome
Comparison of migration at 24 hours as measured by the AirWave system and portable CXR using a Bland-Altman analysis.
Interventions
- OTHER AirWave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-06 |
What the finished NCT01697215 record still lists
NCT01697215 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which AirWave is the first listed.
NCT01697215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01697215 about?
NCT01697215 is a clinical study titled "Novel Device to Assess Endotracheal Tube Migration". To evaluate the ability of the SonarMed AirWave to provide clinicians with information that enables them to confirm continuous proper placement of the endotracheal tube. This initial study is prospective, observational, looking at CXR results, and comparing those to AirWave system output data.
What is the current status of trial NCT01697215?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2012-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01697215?
The interventions under investigation include: AirWave (OTHER).
Who is sponsoring clinical trial NCT01697215?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia